18/120
0.8 / 5 stars
All 120 Win/Lose results shown below
ALDX Roast Me summary
Aldeyra Therapeutics, Inc. (ALDX). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinALDX / S&P 26.04% / 15.20% |
LoseALDX / S&P ALDX unavailable / 15.00% |
LoseALDX / S&P ALDX unavailable / 50.40% |
| 2026-Q10/3 |
LoseALDX / S&P -67.37% / -4.33% |
LoseALDX / S&P ALDX unavailable / 11.30% |
LoseALDX / S&P ALDX unavailable / 27.70% |
| 2025-Q40/3 |
LoseALDX / S&P -0.77% / 2.65% |
LoseALDX / S&P ALDX unavailable / 9.00% |
LoseALDX / S&P ALDX unavailable / 13.40% |
| 2025-Q31/3 |
WinALDX / S&P 36.29% / 8.12% |
LoseALDX / S&P ALDX unavailable / 4.61% |
LoseALDX / S&P ALDX unavailable / 13.45% |
| 2025-Q20/3 |
LoseALDX / S&P -33.39% / 10.94% |
LoseALDX / S&P ALDX unavailable / 4.83% |
LoseALDX / S&P ALDX unavailable / 10.63% |
| 2025-Q11/3 |
WinALDX / S&P 15.23% / -4.27% |
LoseALDX / S&P ALDX unavailable / 4.98% |
LoseALDX / S&P ALDX unavailable / 10.57% |
| 2024-Q40/3 |
LoseALDX / S&P -7.42% / 2.41% |
LoseALDX / S&P ALDX unavailable / 5.25% |
LoseALDX / S&P ALDX unavailable / 6.15% |
| 2024-Q31/3 |
WinALDX / S&P 62.84% / 5.89% |
LoseALDX / S&P ALDX unavailable / 5.89% |
LoseALDX / S&P ALDX unavailable / 6.11% |
| 2024-Q20/3 |
LoseALDX / S&P 1.22% / 4.28% |
LoseALDX / S&P ALDX unavailable / 5.38% |
LoseALDX / S&P ALDX unavailable / 5.12% |
| 2024-Q10/3 |
LoseALDX / S&P -6.84% / 10.56% |
LoseALDX / S&P ALDX unavailable / 5.71% |
LoseALDX / S&P ALDX unavailable / 5.59% |
| 2023-Q40/3 |
LoseALDX / S&P -47.46% / 11.69% |
LoseALDX / S&P ALDX unavailable / 6.81% |
LoseALDX / S&P ALDX unavailable / 7.78% |
| 2023-Q30/3 |
LoseALDX / S&P -20.38% / -3.27% |
LoseALDX / S&P ALDX unavailable / 7.52% |
LoseALDX / S&P ALDX unavailable / -5.03% |
| 2023-Q20/3 |
LoseALDX / S&P -15.51% / 8.74% |
LoseALDX / S&P ALDX unavailable / 9.50% |
LoseALDX / S&P ALDX unavailable / -8.57% |
| 2023-Q11/3 |
WinALDX / S&P 42.67% / 7.50% |
LoseALDX / S&P ALDX unavailable / 10.77% |
LoseALDX / S&P ALDX unavailable / -15.69% |
| 2022-Q41/3 |
WinALDX / S&P 30.34% / 7.56% |
LoseALDX / S&P ALDX unavailable / 11.88% |
LoseALDX / S&P ALDX unavailable / -17.99% |
| 2022-Q31/3 |
WinALDX / S&P 33.83% / -4.88% |
LoseALDX / S&P ALDX unavailable / 13.47% |
LoseALDX / S&P ALDX unavailable / -1.41% |
| 2022-Q21/3 |
WinALDX / S&P -10.24% / -16.10% |
LoseALDX / S&P ALDX unavailable / 13.71% |
LoseALDX / S&P ALDX unavailable / 11.04% |
| 2022-Q11/3 |
WinALDX / S&P 11.13% / -4.60% |
LoseALDX / S&P ALDX unavailable / 15.97% |
LoseALDX / S&P ALDX unavailable / 42.23% |
| 2021-Q40/3 |
LoseALDX / S&P -54.44% / 11.03% |
LoseALDX / S&P ALDX unavailable / 15.00% |
LoseALDX / S&P ALDX unavailable / 96.40% |
| 2021-Q30/3 |
LoseALDX / S&P -22.51% / 0.58% |
LoseALDX / S&P ALDX unavailable / 10.77% |
LoseALDX / S&P ALDX unavailable / 69.42% |
| 2021-Q20/3 |
LoseALDX / S&P -4.63% / 8.55% |
LoseALDX / S&P ALDX unavailable / 6.58% |
LoseALDX / S&P ALDX unavailable / 51.81% |
| 2021-Q11/3 |
WinALDX / S&P 73.18% / 6.17% |
LoseALDX / S&P ALDX unavailable / -1.06% |
LoseALDX / S&P ALDX unavailable / 7.39% |
| 2020-Q40/3 |
LoseALDX / S&P -7.42% / 12.15% |
LoseALDX / S&P ALDX unavailable / -3.72% |
LoseALDX / S&P ALDX unavailable / -33.42% |
| 2020-Q31/3 |
WinALDX / S&P 77.70% / 8.93% |
LoseALDX / S&P ALDX unavailable / -2.04% |
LoseALDX / S&P ALDX unavailable / -27.10% |
| 2020-Q21/3 |
WinALDX / S&P 68.83% / 20.54% |
LoseALDX / S&P ALDX unavailable / -0.46% |
LoseALDX / S&P ALDX unavailable / -27.11% |
| 2020-Q10/3 |
LoseALDX / S&P -57.49% / -19.60% |
LoseALDX / S&P ALDX unavailable / 3.47% |
LoseALDX / S&P ALDX unavailable / -14.75% |
| 2019-Q41/3 |
WinALDX / S&P 10.25% / 9.07% |
LoseALDX / S&P ALDX unavailable / 5.36% |
LoseALDX / S&P ALDX unavailable / 2.99% |
| 2019-Q30/3 |
LoseALDX / S&P -12.17% / 1.70% |
LoseALDX / S&P ALDX unavailable / 5.02% |
LoseALDX / S&P ALDX unavailable / 0.21% |
| 2019-Q20/3 |
LoseALDX / S&P -33.55% / 4.30% |
LoseALDX / S&P ALDX unavailable / 6.64% |
LoseALDX / S&P ALDX unavailable / 8.65% |
| 2019-Q10/3 |
LoseALDX / S&P 8.80% / 13.65% |
LoseALDX / S&P ALDX unavailable / 8.12% |
LoseALDX / S&P ALDX unavailable / 14.29% |
| 2018-Q40/3 |
LoseALDX / S&P -39.86% / -13.52% |
LoseALDX / S&P ALDX unavailable / 9.05% |
LoseALDX / S&P ALDX unavailable / 18.23% |
| 2018-Q31/3 |
WinALDX / S&P 73.58% / 7.71% |
LoseALDX / S&P ALDX unavailable / 10.21% |
LoseALDX / S&P ALDX unavailable / 19.06% |
| 2018-Q21/3 |
WinALDX / S&P 6.00% / 3.43% |
LoseALDX / S&P ALDX unavailable / 9.03% |
LoseALDX / S&P ALDX unavailable / 14.46% |
| 2018-Q11/3 |
WinALDX / S&P 10.29% / -0.76% |
LoseALDX / S&P ALDX unavailable / 7.68% |
LoseALDX / S&P ALDX unavailable / 12.46% |
| 2017-Q40/3 |
LoseALDX / S&P -5.56% / 6.64% |
LoseALDX / S&P ALDX unavailable / 7.03% |
LoseALDX / S&P ALDX unavailable / 13.82% |
| 2017-Q31/3 |
WinALDX / S&P 54.84% / 4.48% |
LoseALDX / S&P ALDX unavailable / 5.68% |
LoseALDX / S&P ALDX unavailable / 17.57% |
| 2017-Q20/3 |
LoseALDX / S&P -7.00% / 3.09% |
LoseALDX / S&P ALDX unavailable / 4.83% |
LoseALDX / S&P ALDX unavailable / 17.74% |
| 2017-Q10/3 |
LoseALDX / S&P -6.54% / 6.07% |
LoseALDX / S&P ALDX unavailable / 3.67% |
LoseALDX / S&P ALDX unavailable / 13.32% |
| 2016-Q40/3 |
LoseALDX / S&P -31.59% / 3.82% |
LoseALDX / S&P ALDX unavailable / 2.09% |
LoseALDX / S&P ALDX unavailable / 7.05% |
| 2016-Q31/3 |
WinALDX / S&P 37.43% / 3.85% |
LoseALDX / S&P ALDX unavailable / 0.20% |
LoseALDX / S&P ALDX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | ALDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -74.82% | 20.78% |
| Annualized return | -74.82% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | ALDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -84.54% | 83.14% |
| Annualized return | -31.16% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | ALDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -72.62% | 319.30% |
| Annualized return | -12.15% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |